ASSEMBLY BIOSCIENCES, INC. Operating Income Loss

• ASSEMBLY BIOSCIENCES, INC. showed an increase of +73.3% in Operating Income Loss from 2024 to 2025.
• This data is from ASSEMBLY BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), ASSEMBLY BIOSCIENCES, INC.'s Operating Income Loss has declined by 262.8%.
• Historical annual values: Fiscal year 2025: -$12.12 million | Fiscal year 2024: -$45.42 million | Fiscal year 2023: -$64.65 million | Fiscal year 2022: -$94.11 million | Fiscal year 2021: -$132.69 million | Fiscal year 2020: -$64.78 million | Fiscal year 2019: -$102.71 million | Fiscal year 2018: -$92.74 million | Fiscal year 2017: -$52.23 million | Fiscal year 2016: -$45.28 million | Fiscal year 2015: -$29.66 million | Fiscal year 2014: -$23.96 million | Fiscal year 2013: -$19.60 million | Fiscal year 2012: -$24.86 million | Fiscal year 2011: -$34.00 million | Fiscal year 2010: -$4.77 million | Fiscal year 2009: -$3.34 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026